DCF — HOLYOKE MEDICAL CENTER
Enterprise Value: $-471.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-471.8M
Enterprise Value
$-145.5M
PV of Cash Flows
$-326.4M
PV of Terminal Value
$-525.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $182.2M | $-31.5M | -17.0% | $-39.2M | $-35.6M |
| Year 2 | $187.7M | $-30.5M | -16.0% | $-38.5M | $-31.8M |
| Year 3 | $193.3M | $-29.5M | -15.0% | $-37.7M | $-28.3M |
| Year 4 | $199.1M | $-29.4M | -15.0% | $-37.8M | $-25.8M |
| Year 5 | $205.1M | $-29.8M | -15.0% | $-38.5M | $-23.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-471.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$176.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.17772955877125235
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5